Xeris Pharmaceuticals Reports Fourth Quarter and Full-year 2020 Financial Results and Recent Highlights

Go back to Xeris Pharmaceuticals Reports Fourth Quarter and Full-year 2020 Financial Results and Recent Highlights
(NASDAQ: XERS) Delayed: 8.39 +0.40 (5.01%)
Previous Close $7.99    52 Week High
Open $8.00    52 Week Low
Day High $8.44    P/E N/A 
Day Low $7.96    EPS
Volume 1,776,551